Ulipristal-d3

Ulipristal-d3

• UNSPSC Description: Ulipristal-d3 (CDB-3236-d3) is deuterium labeled Ulipristal. Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1][2].
• Target Antigen: Isotope-Labeled Compounds; Progesterone Receptor
• Type: Isotope-Labeled Compounds
• Related Pathways: Others;Vitamin D Related/Nuclear Receptor
• Field of Research: Cancer;Endocrinology
• Smiles: [H][C@@]12CCC3=CC(CCC3=C1[C@H](C[C@]4([C@@]2([H])CC[C@@]4(C(C)=O)O)C)C5=CC=C(C=C5)N(C)C([2H])([2H])[2H])=O
• Molecular Weight: 436.60
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]LIANA PLES, et al. Is Ulipristal Acetate a Liver Toxic Biomolecule? Toxicity assessment of ulipristal acetate. REV.CHIM.(Bucharest).
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported